Publications by authors named "Ippei Fukada"

Claim this Profile
R
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.
Meiko Nishimura, Takayuki Kobayashi, Yosuke Aoyama, Saori Kawai, Jun Masuda, Ippei Fukada

Breast Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first case of fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib.
Takehiro Nakao, Naoki Fukuda, Xiaofei Wang, Ryosuke Oki, Tetsuya Urasaki, Ippei Fukada

Int Cancer Conf J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinib.
Naoki Fukuda, Kazuhisa Toda, Tomohiro Chiba, Ippei Fukada, Seiichi Mori

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and clinical characteristics of cranial nerve schwannoma harboring SH3PXD2A-HTRA1 fusion gene.
Junki Sogano, Ryota Tamura, Masahiro Yo, Kohei Nakamura, Ippei Fukada

Acta Neuropathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinoma.
Takaaki Furukawa, Ippei Fukada, Naomi Hayashi, Takeshi Okamoto, Yoichiro Sato

Pancreatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical potential of antibody-drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumors.
Ippei Miyamoto, Takahiro Kogawa, Kana Kurokawa, Eriko Miyawaki, Yohei Arihara, Ippei Fukada

Invest New Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors.
Hiu Ting Chan, Masumi Otaki, Naomi Hayashi, Ippei Fukada, Yoon Ming Chin

Clin Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.
Yosuke Aoyama, Yukinori Ozaki, Rika Kizawa, Jun Masuda, Saori Kawai, Ippei Fukada

Breast Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers.
Mari Hosonaga, Eri Habano, Hiromi Arakawa, Keika Kaneko, Takeshi Nakajima, Ippei Fukada

Breast Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study.
Takuya Tomomatsu, Hisanori Shimizu, Takashi Yokokawa, Ippei Fukada, Kazuyoshi Kawakami

Yakugaku Zasshi· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancer.
Takayuki Kobayashi, Meiko Nishimura, Mari Hosonaga, Rika Kizawa, Saori Kawai, Ippei Fukada

BMC Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Investigation of the Changes in Blood Cell Components following the Administration of Pegfilgrastim in Neo-Adjuvant and Adjuvant FEC Chemotherapy for Breast Cancer].
Maimi Asano, Hisanori Shimizu, Takashi Yokokawa, Wataru Suzuki, Kazuyoshi Kawakami, Ippei Fukada

Gan To Kagaku Ryoho· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Availability of genome-matched therapy based on clinical practice.
Naomi Hayashi, Seiichi Mori, Akihiro Ohmoto, Ippei Fukada, Masumi Yamazaki

Int J Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Overview of Clinical Application of Whole Genome Analysis for Cancer].
Ippei Fukada

Gan To Kagaku Ryoho· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.
Ippei Fukada, Seiichi Mori, Naomi Hayashi, Mari Hosonaga, Wang Xiaofei

Cancer Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Druggable gene alterations in Japanese patients with rare malignancy.
Akihiro Ohmoto, Naomi Hayashi, Ippei Fukada, Masumi Yamazaki, Mayu Yunokawa

Neoplasia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling.
Naomi Hayashi, Ippei Fukada, Akihiro Ohmoto, Masumi Yamazaki, Xiaofei Wang

Discov Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
Yoon Ming Chin, Tomoko Shibayama, Hiu Ting Chan, Masumi Otaki, Fumikata Hara, Ippei Fukada

Cancer Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a cancer genomic profile test for patients with metastatic breast cancer.
Ippei Fukada, Seiichi Mori, Naomi Hayashi, Mari Hosonaga, Masumi Yamazaki

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
Yukinori Ozaki, Yosuke Aoyama, Jun Masuda, Lina Inagaki, Saori Kawai, Ippei Fukada

BMC Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).
Ippei Fukada, Yoshinori Ito, Naoto Kondo, Shoichiro Ohtani, Masaya Hattori

Breast Cancer Res Treat· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer.
Tomoko Shibayama, Siew-Kee Low, Makiko Ono, Takayuki Kobayashi, Kokoro Kobayashi, Ippei Fukada

Breast Cancer Res Treat· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.
Kazuhiro Araki, Yoshinori Ito, Ippei Fukada, Kokoro Kobayashi, Yoshimasa Miyagawa

BMC Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
Ippei Fukada, Yoshinori Ito, Kokoro Kobayashi, Tomoko Shibayama, Shunji Takahashi

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy.
Tomomi Abe, Ippei Fukada, Taro Shiga, Hidetomo Morizono, Koichi Ikebata

Case Rep Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis